Up a level |
Elvebakken, Hege; Venizelos, Andreas; Perren, Aurel; Couvelard, Anne; Lothe, Inger Marie B; Hjortland, Geir O; Myklebust, Tor Å; Svensson, Johanna; Garresori, Herish; Kersten, Christian; Hofsli, Eva; Detlefsen, Sönke; Vestermark, Lene W; Knappskog, Stian; Sorbye, Halfdan (2024). Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms. British journal of cancer, 131(4), pp. 676-684. Springer Nature 10.1038/s41416-024-02773-w
Morken, Siren; Langer, Seppo W; Sundlöv, Anna; Vestermark, Lene Weber; Ladekarl, Morten; Hjortland, Geir Olav; Svensson, Johanna B; Tabaksblat, Elizaveta Mitkina; Haslerud, Torjan Magne; Assmus, Jörg; Detlefsen, Sönke; Couvelard, Anne; Perren, Aurel; Sorbye, Halfdan (2023). Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms. British journal of cancer, 129(12), pp. 1930-1939. Nature Publishing Group 10.1038/s41416-023-02462-0
Venizelos, Andreas; Sorbye, Halfdan; Elvebakken, Hege; Perren, Aurel; Lothe, Inger Marie B; Couvelard, Anne; Hjortland, Geir Olav; Sundlöv, Anna; Svensson, Johanna; Garresori, Harrish; Kersten, Christian; Hofsli, Eva; Detlefsen, Sönke; Vestermark, Lene W; Ladekarl, Morten; Tabaksblat, Elizaveta Mitkina; Knappskog, Stian (2023). Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer, 30(10) BioScientifica 10.1530/ERC-23-0057
Venizelos, Andreas; Elvebakken, Hege; Perren, Aurel; Nikolaienko, Oleksii; Deng, Wei; Lothe, Inger Marie B; Couvelard, Anne; Hjortland, Geir Olav; Sundlöv, Anna; Svensson, Johanna; Garresori, Harrish; Kersten, Christian; Hofsli, Eva; Detlefsen, Sönke; Krogh, Merete; Sorbye, Halfdan; Knappskog, Stian (2021). The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer, 29(1), pp. 1-14. BioScientifica Ltd. 10.1530/ERC-21-0152